Efficacy and Safety of MLC601 in Patients with Mild to Moderate Alzheimer Disease: An Extension 4-Year Follow-Up Study

Hossein Pakdaman, Koroush Gharagozli, Mehdi Abbasi, Ali Sobhanian, Ali Bakhshandehpour, Farzad Ashrafi, Mitra Khalilzad, Ali Amini Harandi
  • Dementia and Geriatric Cognitive Disorders Extra, April 2018, Karger Publishers
  • DOI: 10.1159/000488482

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1159/000488482

The following have contributed to this page: Dr Mehdi Abbasi